The scientists reported that the treatment reduced the average PASI score by one to seven points [20]
A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: further link between metabolism and psychopathology: special section on translational and neuroscience studies in affective disorders
3 After propensity-score matching for age, BMI, breast density, race, ethnicity, and diabetes history (n=30,528), breast cancer occurred in 1.62% (247/15,264) of GLP-1 users over the study period of 3.5 years, compared with 2.31% (353/15,264) of matched non-users
Beta-Glucan: Sources: Oats, barley
That number increased when the researchers used computer statistical modeling to see what might happen beyond that first year
Peptide storage isn't forgiving